In many ways, 2020 was an unprecedented year. In midMarch, the United States abruptly went into lockdown as coronavirus cases began to spike; a national emergency was declared, travel bans and gathering restrictions were...more
4/28/2021
/ Class Action ,
Data Breach ,
Dismissals ,
Duty to Disclose ,
Failure To Disclose ,
False Statements ,
Initial Public Offering (IPO) ,
Investors ,
Misleading Statements ,
Omissions ,
Popular ,
Publicly-Traded Companies ,
Securities and Exchange Commission (SEC) ,
Securities Exchange Act ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Shareholder Litigation ,
Stock Prices
California Federal Court Denies Motion to Dismiss Securities Class Action Arising from Uber’s IPO; S.D.N.Y. Dismisses Ponzi Scheme Action Against HSBC Hong Kong for Lack of Personal Jurisdiction; Delaware Court of Chancery...more
8/27/2020
/ Advisory Committee ,
Appraisal Rights ,
Class Action ,
Dismissals ,
False Statements ,
Food and Drug Administration (FDA) ,
Initial Public Offering (IPO) ,
Investors ,
Legal Fees ,
Material Misrepresentation ,
Misleading Statements ,
Misrepresentation ,
Motion to Dismiss ,
Negligence ,
Omissions ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Ponzi Scheme ,
Putative Class Actions ,
Securities Act of 1933 ,
Securities Fraud ,
Securities Litigation ,
Securities Violations ,
Shareholders ,
Strict Liability ,
Uber